rs55812846

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_020639.3(RIPK4):​c.1884C>T​(p.Ser628Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0053 in 1,608,500 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0047 ( 8 hom., cov: 35)
Exomes 𝑓: 0.0054 ( 34 hom. )

Consequence

RIPK4
NM_020639.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -4.91

Publications

1 publications found
Variant links:
Genes affected
RIPK4 (HGNC:496): (receptor interacting serine/threonine kinase 4) The protein encoded by this gene is a serine/threonine protein kinase that interacts with protein kinase C-delta. The encoded protein can also activate NFkappaB and is required for keratinocyte differentiation. This kinase undergoes autophosphorylation. [provided by RefSeq, Jul 2008]
RIPK4 Gene-Disease associations (from GenCC):
  • Bartsocas-Papas syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • ectodermal dysplasia syndrome
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 21-41741309-G-A is Benign according to our data. Variant chr21-41741309-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 191165.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.91 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00474 (722/152298) while in subpopulation NFE AF = 0.00541 (368/68010). AF 95% confidence interval is 0.00496. There are 8 homozygotes in GnomAd4. There are 343 alleles in the male GnomAd4 subpopulation. Median coverage is 35. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RIPK4NM_020639.3 linkc.1884C>T p.Ser628Ser synonymous_variant Exon 8 of 8 ENST00000332512.8 NP_065690.2 Q9H4D1Q96T11

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RIPK4ENST00000332512.8 linkc.1884C>T p.Ser628Ser synonymous_variant Exon 8 of 8 1 NM_020639.3 ENSP00000332454.3 P57078-2
RIPK4ENST00000352483.3 linkc.2028C>T p.Ser676Ser synonymous_variant Exon 9 of 9 5 ENSP00000330161.2 P57078-1
ENSG00000236883ENST00000423276.1 linkn.*1G>A downstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.00474
AC:
722
AN:
152180
Hom.:
8
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.00138
Gnomad AMI
AF:
0.0681
Gnomad AMR
AF:
0.00249
Gnomad ASJ
AF:
0.00980
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.0132
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00541
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00538
AC:
1310
AN:
243718
AF XY:
0.00546
show subpopulations
Gnomad AFR exome
AF:
0.00133
Gnomad AMR exome
AF:
0.00136
Gnomad ASJ exome
AF:
0.0105
Gnomad EAS exome
AF:
0.000111
Gnomad FIN exome
AF:
0.0152
Gnomad NFE exome
AF:
0.00724
Gnomad OTH exome
AF:
0.00398
GnomAD4 exome
AF:
0.00536
AC:
7803
AN:
1456202
Hom.:
34
Cov.:
92
AF XY:
0.00526
AC XY:
3813
AN XY:
724708
show subpopulations
African (AFR)
AF:
0.000867
AC:
29
AN:
33464
American (AMR)
AF:
0.00168
AC:
75
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.00989
AC:
258
AN:
26090
East Asian (EAS)
AF:
0.00123
AC:
49
AN:
39680
South Asian (SAS)
AF:
0.00113
AC:
97
AN:
86210
European-Finnish (FIN)
AF:
0.0136
AC:
657
AN:
48302
Middle Eastern (MID)
AF:
0.0104
AC:
60
AN:
5766
European-Non Finnish (NFE)
AF:
0.00568
AC:
6310
AN:
1111668
Other (OTH)
AF:
0.00444
AC:
268
AN:
60328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
562
1124
1687
2249
2811
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
240
480
720
960
1200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00474
AC:
722
AN:
152298
Hom.:
8
Cov.:
35
AF XY:
0.00461
AC XY:
343
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00137
AC:
57
AN:
41568
American (AMR)
AF:
0.00248
AC:
38
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00980
AC:
34
AN:
3470
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5174
South Asian (SAS)
AF:
0.00186
AC:
9
AN:
4830
European-Finnish (FIN)
AF:
0.0132
AC:
140
AN:
10626
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00541
AC:
368
AN:
68010
Other (OTH)
AF:
0.00379
AC:
8
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
39
78
116
155
194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00555
Hom.:
3
Bravo
AF:
0.00420
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00567
EpiControl
AF:
0.00545

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Sep 28, 2016
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Bartsocas-Papas syndrome 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

RIPK4-related disorder Benign:1
Nov 19, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.32
DANN
Benign
0.87
PhyloP100
-4.9
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55812846; hg19: chr21-43161469; COSMIC: COSV60188551; COSMIC: COSV60188551; API